HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

QINGSONG HEALTH

4.470

-0.360-7.45%

Volume:49.58M

Turnover:244.02M

Market Cap:920.82M

PE:-0.98

High:5.460

Open:4.970

Low:4.365

Close:4.830

52wk High:162.700

52wk Low:4.365

Shares:206.00M

HK Float Shares:206.00M

Volume Ratio:7.78

T/O Rate:24.07%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-4.580

ROE:--

ROA:-1.96%

PB:0.86

PE(LYR):-0.98

PS:0.82

Loading ...

Overview Company News Filings

Qingsong Health proposes 2026 share incentive scheme with 10% share cap

Stock Track | QINGSONG HEALTH Soars 5.67% Intraday on AI Medical Product Integration

Capital Expenditure Supercycle in AI Drives Funds to Power and Data Center Sectors

QINGSONG HEALTH Integrates "Zhengyuanfang" AI into Its "Yilu Qingsong" Professional Platform

QingSong Health embeds “QSevidence” into QSmedical; physician users rise 46.4% to 69,615

Bulletin Express

Qingsong Health embeds QSevidence AI medical agent into QSmedical platform

Co-Founder's Sudden Exit Wipes Out $5 Billion from Beijing Entrepreneur's AI Health Venture

Qingsong Health says unaware of reasons for unusual share price movements

Qingsong Health Announces New Independent Non-Executive Director

Qingsong Health appoints Ji Wenting as independent non-executive director

Qingsong Health Corp - MS. Wang Jing Resigns as Executive Director and CFO Effective April 17, 2026

THOMSON REUTERS

QingSong Health Reports Stable Share Capital and Confirms Public Float Compliance for March 2026

Bulletin Express

QINGSONG HEALTH Reports Strong Annual Figures Amid Scrutiny Over Elderly Targeting and Customer Service Failures

QingSong Health SEHK 2661 Half Year Profit Of ¥86m Tests Bearish Narratives

Simply Wall St.

Analyzing Qingsong Health's (02661) First Post-IPO Report: Integrating AI into Growth Strategy for Tangible Results

QingSong Health Appoints New Joint Company Secretary, Secures Extended HKEX Compliance Waiver

Bulletin Express

QINGSONG HEALTH Reports 2025 Results: Adjusted Net Profit Rises 9.0% to RMB92 Million

Qingsong Health Announces Management Reshuffle: Chen Jingya Appointed as Joint Company Secretary

Qingsong Health appoints Chan Ching Nga as joint company secretary and process agent

Qingsong Health FY2025 revenue rose 32.9% to RMB 1.26 billion as loss from continuing operations totaled RMB 379.72 million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/02661/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"02661","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02661\",,,,,undefined,":{"symbol":"02661","market":"HK","secType":"STK","nameCN":"QINGSONG HEALTH","latestPrice":4.47,"timestamp":1789107120115,"preClose":4.83,"halted":0,"volume":49580800,"delay":0,"changeRate":-0.0745341614906833,"floatShares":206000000,"shares":206000000,"eps":-4.58,"marketStatus":"Trading","change":-0.36,"latestTime":"09-11 14:12:13","open":4.97,"high":5.46,"low":4.365,"amount":244023482,"amplitude":0.226708,"askPrice":4.48,"askSize":1000,"bidPrice":4.465,"bidSize":5000,"shortable":0,"etf":0,"ttmEps":-2.884,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789114200000},"marketStatusCode":2,"adr":0,"listingDate":1766419200000,"exchange":"SEHK","adjPreClose":4.83,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"volumeRatio":7.780693,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02661\",,,,,undefined,":{"symbol":"02661","floatShares":206000000,"roa":"-1.96%","roe":"--","lyrEps":-4.58,"volumeRatio":7.780693,"shares":206000000,"dividePrice":0,"high":5.46,"amplitude":0.226708,"preClose":4.83,"low":4.365,"week52Low":4.365,"pbRate":"0.86","psRate":"0.82","week52High":162.7,"institutionHeld":0,"latestPrice":4.47,"committee":0.666667,"eps":-4.58,"divideRate":0,"volume":49580800,"delay":0,"ttmEps":-2.884,"open":4.97,"prevYearClose":68.55,"prevWeekClose":4.985,"prevMonthClose":4.895,"prevQuarterClose":12.12,"fiveDayClose":4.985,"twentyDayClose":5.535,"sixtyDayClose":12.44},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02661\",params:#limit:5,,,undefined,":[{"date":"2026-08-24","symbol":"02661","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787535000000,"name":null,"time":"","dateTimestamp":1787500800000,"actualEps":null},{"date":"2026-03-23","symbol":"02661","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774229400000,"name":null,"time":"","dateTimestamp":1774195200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02661\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02661\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02661\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02661","date":"2026-09-10","current":-1.549931,"percent":0.62069,"low":-77.230484,"twenty":-12.495698,"median":-2.744559,"eighty":208.223396,"high":330.717659,"avg":65.381654,"sd":116.787633,"marketCap":986934229},"quantilePoints":[{"date":"2025-12-24","current":154.578053,"twenty":86.000631,"median":136.059733,"eighty":147.170725,"marketCap":13785797161},{"date":"2026-01-02","current":172.181342,"twenty":137.743838,"median":154.522148,"eighty":157.33739,"marketCap":15416153412},{"date":"2026-01-09","current":199.919447,"twenty":146.488637,"median":165.104283,"eighty":191.152559,"marketCap":17944237472},{"date":"2026-01-16","current":254.160459,"twenty":154.533329,"median":187.274166,"eighty":207.316491,"marketCap":22886899778},{"date":"2026-01-23","current":231.235134,"twenty":155.267887,"median":199.193,"eighty":241.586945,"marketCap":20802520267},{"date":"2026-01-30","current":227.214227,"twenty":160.858048,"median":208.418497,"eighty":236.459477,"marketCap":20534233795},{"date":"2026-02-06","current":216.844907,"twenty":174.538164,"median":216.183465,"eighty":235.161153,"marketCap":19646824696},{"date":"2026-02-13","current":181.068689,"twenty":173.687038,"median":212.972677,"eighty":234.511447,"marketCap":16499618009},{"date":"2026-02-20","current":185.412344,"twenty":176.698431,"median":208.418497,"eighty":234.173998,"marketCap":16871091585},{"date":"2026-02-27","current":204.040601,"twenty":180.525143,"median":205.218405,"eighty":232.2757,"marketCap":18769734308},{"date":"2026-03-06","current":195.973689,"twenty":182.806746,"median":206.742408,"eighty":229.074604,"marketCap":17882325209},{"date":"2026-03-13","current":291.093206,"twenty":184.833587,"median":210.695587,"eighty":234.173998,"marketCap":26684185223},{"date":"2026-03-20","current":329.261305,"twenty":186.529437,"median":215.356305,"eighty":243.704335,"marketCap":30068722251},{"date":"2026-03-27","current":-77.230484,"twenty":182.806746,"median":214.315884,"eighty":244.482121,"marketCap":33205610228},{"date":"2026-04-02","current":-67.784903,"twenty":172.103078,"median":210.695587,"eighty":243.899684,"marketCap":29284500257},{"date":"2026-04-10","current":-69.020043,"twenty":154.578053,"median":208.174621,"eighty":243.313638,"marketCap":30048084830},{"date":"2026-04-17","current":-72.1658,"twenty":52.627897,"median":205.218406,"eighty":236.753996,"marketCap":31430792030},{"date":"2026-04-24","current":-23.8091,"twenty":-28.522192,"median":202.908467,"eighty":235.281399,"marketCap":10370304002},{"date":"2026-04-30","current":-24.8688,"twenty":-25.599479,"median":198.522494,"eighty":234.800417,"marketCap":10834645972},{"date":"2026-05-08","current":-18.985971,"twenty":-27.574394,"median":195.099007,"eighty":234.005274,"marketCap":8300370685},{"date":"2026-05-15","current":-11.930444,"twenty":-25.362529,"median":192.122157,"eighty":231.755417,"marketCap":5229522456},{"date":"2026-05-22","current":-11.410376,"twenty":-24.455767,"median":184.688897,"eighty":229.498316,"marketCap":4990128373},{"date":"2026-05-29","current":-11.361431,"twenty":-24.239097,"median":180.389256,"eighty":228.789335,"marketCap":4986000889},{"date":"2026-06-05","current":-8.917256,"twenty":-23.951301,"median":172.050902,"eighty":228.023011,"marketCap":3919046228},{"date":"2026-06-12","current":-6.456347,"twenty":-23.809397,"median":154.5501,"eighty":227.382237,"marketCap":2835581631},{"date":"2026-06-18","current":-6.499011,"twenty":-23.8091,"median":140.269996,"eighty":226.809177,"marketCap":2860346536},{"date":"2026-06-26","current":-6.618533,"twenty":-23.805294,"median":-5.524671,"eighty":224.904743,"marketCap":2899557636},{"date":"2026-07-03","current":-4.448284,"twenty":-22.836861,"median":-5.524671,"eighty":222.769568,"marketCap":1950236275},{"date":"2026-07-10","current":-3.478166,"twenty":-18.932315,"median":-4.354952,"eighty":221.049103,"marketCap":1523041662},{"date":"2026-07-17","current":-3.071347,"twenty":-18.717429,"median":-3.952394,"eighty":217.133309,"marketCap":1349687326},{"date":"2026-07-24","current":-2.831202,"twenty":-18.692878,"median":-3.518961,"eighty":216.644762,"marketCap":1244436480},{"date":"2026-07-31","current":-2.778971,"twenty":-18.598888,"median":-3.30785,"eighty":215.84418,"marketCap":1223799059},{"date":"2026-08-07","current":-2.752538,"twenty":-18.238526,"median":-3.071347,"eighty":215.522023,"marketCap":1214512219},{"date":"2026-08-14","current":-2.585563,"twenty":-13.819412,"median":-2.985862,"eighty":215.356305,"marketCap":1142281246},{"date":"2026-08-21","current":-2.423718,"twenty":-13.427581,"median":-2.837447,"eighty":213.275464,"marketCap":1073145886},{"date":"2026-08-28","current":-1.702467,"twenty":-13.241392,"median":-2.817192,"eighty":212.972677,"marketCap":1026779400},{"date":"2026-09-04","current":-1.688237,"twenty":-12.722796,"median":-2.778971,"eighty":208.418497,"marketCap":1018606031},{"date":"2026-09-10","current":-1.633539,"twenty":-12.495698,"median":-2.744559,"eighty":208.223396,"marketCap":986934229}],"updateTime":1789107133501},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02661\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2631569506","title":"Qingsong Health proposes 2026 share incentive scheme with 10% share cap","url":"https://stock-news.laohu8.com/highlight/detail?id=2631569506","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2631569506?lang=en_us&edition=fundamental","pubTime":"2026-04-30 22:32","pubTimestamp":1777559543,"startTime":"0","endTime":"0","summary":"Qingsong Health board moved to put a 2026 Share Incentive Scheme to a shareholder vote at AGM scheduled for May 22, 2026.Scheme share limit set at up to 10% of issued share capital at approval date.Plan designed to use treasury shares plus existing shares bought in on-market or off-market transactions.Company disclosed 28,089,854 share options remain outstanding under pre-IPO share option scheme, representing 13.61% of issued share capital.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qingsong Health Corporation published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 30, 2026, and is solely responsible for the information contained th","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260430:nNDL22VYf9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02661","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1123403210","title":"Stock Track | QINGSONG HEALTH Soars 5.67% Intraday on AI Medical Product Integration","url":"https://stock-news.laohu8.com/highlight/detail?id=1123403210","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123403210?lang=en_us&edition=fundamental","pubTime":"2026-04-27 09:35","pubTimestamp":1777253701,"startTime":"0","endTime":"0","summary":"QINGSONG HEALTH's stock surged 5.67% during intraday trading on Monday, following the company's announcement of a significant integration of its artificial intelligence capabilities.The healthcare...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["02661"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180522876","title":"Capital Expenditure Supercycle in AI Drives Funds to Power and Data Center Sectors","url":"https://stock-news.laohu8.com/highlight/detail?id=1180522876","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180522876?lang=en_us&edition=fundamental","pubTime":"2026-04-27 07:16","pubTimestamp":1777245411,"startTime":"0","endTime":"0","summary":"In the flow of capital within the U.S. stock market, investment is accelerating towards targets related to power infrastructure and AI data centers. Tony Pasquariello, head of Goldman Sachs' hedge...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02661","LU0173614495.USD","VXUS","LU0287142896.SGD","01330","SG9999014674.SGD","LU1720050803.USD","159940","BK4585","BK1538","BK1554","BK1147","BK1505","01021","BK1140","BK1183","LU1794554557.SGD","BK1516","01088","BK1178","06030","BK1564","BK1148","BK1594","BK1521","BK4588","BK1219","BK1537","01799"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102620936","title":"QINGSONG HEALTH Integrates \"Zhengyuanfang\" AI into Its \"Yilu Qingsong\" Professional Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=1102620936","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102620936?lang=en_us&edition=fundamental","pubTime":"2026-04-26 19:28","pubTimestamp":1777202914,"startTime":"0","endTime":"0","summary":"QINGSONG HEALTH (02661) has announced the official integration of its self-developed artificial intelligence evidence-based medicine agent, \"Zhengyuanfang,\" into the Group's professional service...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1219","02661"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136926707","title":"QingSong Health embeds “QSevidence” into QSmedical; physician users rise 46.4% to 69,615","url":"https://stock-news.laohu8.com/highlight/detail?id=1136926707","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136926707?lang=en_us&edition=fundamental","pubTime":"2026-04-26 19:22","pubTimestamp":1777202568,"startTime":"0","endTime":"0","summary":"QingSong Health Corporation (HKEX: 02661) has completed the integration of its self-developed AI evidence-based medical agent, “QSevidence,” into the Group’s professional healthcare platform,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02661"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630382026","title":"Qingsong Health embeds QSevidence AI medical agent into QSmedical platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2630382026","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630382026?lang=en_us&edition=fundamental","pubTime":"2026-04-26 19:20","pubTimestamp":1777202436,"startTime":"0","endTime":"0","summary":"Qingsong Health embedded self-developed AI evidence-based medical agent product QSevidence into physician platform QSmedical, shifting use case toward clinical decision support.Medical professional users on QSmedical reached 69,615 as of March 31, 2026, up 46.4% from 47,554 a year earlier.Ophthalmology medical professional users rose to 3,672, up 171% from 1,355.Physicians at or above associate chief level increased to 36,678, up 42.7% from 25,701.Senior physicians represented about 52.7% of platform medical professional users as of March 31, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qingsong Health Corporation published the original content used to generate this news brief via IIS, the Issuer Information Service operated by","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260426:nNDL6sPkMP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1219","02661"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106218752","title":"Co-Founder's Sudden Exit Wipes Out $5 Billion from Beijing Entrepreneur's AI Health Venture","url":"https://stock-news.laohu8.com/highlight/detail?id=1106218752","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106218752?lang=en_us&edition=fundamental","pubTime":"2026-04-22 20:21","pubTimestamp":1776860486,"startTime":"0","endTime":"0","summary":"An emerging AI-focused company is experiencing a severe market chill. On April 22, the stock price of QINGSONG HEALTH fell another 16.6%, reducing its market capitalization to HK$10.37 billion. In...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARTY","02661","AGIX","BK1219","IPOS","CHAT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629772150","title":"Qingsong Health says unaware of reasons for unusual share price movements","url":"https://stock-news.laohu8.com/highlight/detail?id=2629772150","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629772150?lang=en_us&edition=fundamental","pubTime":"2026-04-21 07:42","pubTimestamp":1776728533,"startTime":"0","endTime":"0","summary":"Qingsong Health issued a voluntary statement addressing unusual share-price movements in its Hong Kong-listed stock .Board said it is not aware of any reason for recent price fluctuations as of April 21, 2026.Directors said they are not aware of any undisclosed information needed to avoid a false market or any inside information requiring disclosure under Hong Kong listing rules.Group said operations remain normal as of announcement date.Board said substantial shareholders or directors did not sell shares during period of unusual price movement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qingsong Health Corporation published the original content used to generate this news brief via IIS, the Issuer Information Service operated by th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260420:nNDL58JQVm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02661","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157323768","title":"Qingsong Health Announces New Independent Non-Executive Director","url":"https://stock-news.laohu8.com/highlight/detail?id=1157323768","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157323768?lang=en_us&edition=fundamental","pubTime":"2026-04-17 21:04","pubTimestamp":1776431058,"startTime":"0","endTime":"0","summary":"Qingsong Health (02661) has announced that Ms. Wang Jing has retired from her roles as executive director and chief financial officer, effective April 17, 2026. Her decision was based on a desire to...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02661","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628420912","title":"Qingsong Health appoints Ji Wenting as independent non-executive director","url":"https://stock-news.laohu8.com/highlight/detail?id=2628420912","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628420912?lang=en_us&edition=fundamental","pubTime":"2026-04-17 20:55","pubTimestamp":1776430533,"startTime":"0","endTime":"0","summary":"Qingsong Health named Ji Wenting independent non-executive director effective April 17, 2026.Ji also took over as audit committee chair, replacing Bai Kun.Ji is chief financial officer of Cheche Group; prior roles include CFO at Quhuo and Xiaoyezi Music Technology Group.Yang Yin was appointed authorized representative effective April 17, 2026, replacing Wang.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qingsong Health Corporation published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on April 17, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nNDLb3Dgfk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4173","02661","CCG","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628820913","title":"Qingsong Health Corp - MS. Wang Jing Resigns as Executive Director and CFO Effective April 17, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2628820913","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628820913?lang=en_us&edition=fundamental","pubTime":"2026-04-17 20:55","pubTimestamp":1776430511,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260417:nFWN4100JL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["02661","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148874740","title":"QingSong Health Reports Stable Share Capital and Confirms Public Float Compliance for March 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1148874740","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148874740?lang=en_us&edition=fundamental","pubTime":"2026-04-08 17:41","pubTimestamp":1775641274,"startTime":"0","endTime":"0","summary":"QingSong Health Corporation (QingSong Health) filed its Monthly Return for Equity Issuers for the period ended 31 March 2026, indicating a stable share structure and continued adherence to Hong Kong...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02661"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132414833","title":"QINGSONG HEALTH Reports Strong Annual Figures Amid Scrutiny Over Elderly Targeting and Customer Service Failures","url":"https://stock-news.laohu8.com/highlight/detail?id=1132414833","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132414833?lang=en_us&edition=fundamental","pubTime":"2026-03-26 17:02","pubTimestamp":1774515757,"startTime":"0","endTime":"0","summary":"QINGSONG HEALTH Group recently released its full-year 2025 results, marking its first annual report since going public. The figures appeared robust at first glance. On one hand, the company...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02661","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622979079","title":"QingSong Health SEHK 2661 Half Year Profit Of ¥86m Tests Bearish Narratives","url":"https://stock-news.laohu8.com/highlight/detail?id=2622979079","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622979079?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:13","pubTimestamp":1774437239,"startTime":"0","endTime":"0","summary":"QingSong Health (SEHK:2661) has released its FY 2025 scorecard with first half revenue of ¥656.1 million and basic EPS of ¥1.07, against a backdrop where trailing 12 month revenue reached ¥1.26 billion and EPS stood at a loss of ¥4.58. Over recent reporting periods, the company has seen revenue move from ¥489.9 million in 2H 2023 to ¥945.0 million in 2H 2024 and up to ¥1.26 billion on a trailing 12 month basis, while EPS shifted from ¥1.21 to ¥0.11 and then to a loss of ¥4.58. For investors,...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/healthcare/hkg-2661/qingsong-health-shares/news/qingsong-health-sehk-2661-half-year-profit-of-86m-tests-bear","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/healthcare/hkg-2661/qingsong-health-shares/news/qingsong-health-sehk-2661-half-year-profit-of-86m-tests-bear","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["02661","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181387464","title":"Analyzing Qingsong Health's (02661) First Post-IPO Report: Integrating AI into Growth Strategy for Tangible Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1181387464","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181387464?lang=en_us&edition=fundamental","pubTime":"2026-03-24 16:19","pubTimestamp":1774340360,"startTime":"0","endTime":"0","summary":"As AI becomes a dominant theme, more companies are discussing large models, intelligent agents, and real-world applications. However, for capital markets, what truly matters is not just what is said,...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1219","02661"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194562233","title":"QingSong Health Appoints New Joint Company Secretary, Secures Extended HKEX Compliance Waiver","url":"https://stock-news.laohu8.com/highlight/detail?id=1194562233","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194562233?lang=en_us&edition=fundamental","pubTime":"2026-03-23 22:21","pubTimestamp":1774275700,"startTime":"0","endTime":"0","summary":"QingSong Health Corporation announced personnel changes and a related regulatory waiver affecting its company secretarial function, effective 23 March 2026. Mr. CHOW Shing Lung has resigned as Joint...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02661"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118571262","title":"QINGSONG HEALTH Reports 2025 Results: Adjusted Net Profit Rises 9.0% to RMB92 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=1118571262","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118571262?lang=en_us&edition=fundamental","pubTime":"2026-03-23 21:58","pubTimestamp":1774274319,"startTime":"0","endTime":"0","summary":"QINGSONG HEALTH (02661) announced its financial results for 2025. Revenue reached approximately RMB1.256 billion, representing a year-on-year increase of 32.9%. Gross profit grew by 20.3% to RMB435...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02661","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148190453","title":"Qingsong Health Announces Management Reshuffle: Chen Jingya Appointed as Joint Company Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=1148190453","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148190453?lang=en_us&edition=fundamental","pubTime":"2026-03-23 21:58","pubTimestamp":1774274302,"startTime":"0","endTime":"0","summary":"Qingsong Health (02661) has announced that Mr. Zou Xinglong has resigned from his positions as joint company secretary and as the company's authorized representative in Hong Kong for receiving legal...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02661","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621270137","title":"Qingsong Health appoints Chan Ching Nga as joint company secretary and process agent","url":"https://stock-news.laohu8.com/highlight/detail?id=2621270137","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621270137?lang=en_us&edition=fundamental","pubTime":"2026-03-23 21:52","pubTimestamp":1774273950,"startTime":"0","endTime":"0","summary":"Qingsong Health said Shing Lung Chow resigned as joint company secretary and process agent, effective March 23, 2026.Chan is a Senior Manager, Entity Solutions at Computershare Hong Kong Investor Services and has over 20 years of company secretarial and corporate governance experience.Lei Yang will continue as the other joint company secretary and has served as the company’s strategy and investor relations specialist since April 2023.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qingsong Health Corporation published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange  , on March 23, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDLMbqCN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7503","CPU.AU","02661","BK7033","BK7157","BK1219"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621701881","title":"Qingsong Health FY2025 revenue rose 32.9% to RMB 1.26 billion as loss from continuing operations totaled RMB 379.72 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2621701881","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621701881?lang=en_us&edition=fundamental","pubTime":"2026-03-23 21:46","pubTimestamp":1774273571,"startTime":"0","endTime":"0","summary":"Qingsong Health published an annual results announcement for the year ended Dec. 31, 2025, reporting revenue of RMB 1.3 billion, up 32.9%.Gross profit was RMB 435.1 million, up 20.3%, while gross profit margin was 34.6%, down 3.7 percentage points.Loss from continuing operations was RMB 379.7 million, versus a profit in the prior year, primarily due to fair value changes of convertible redeemable preferred shares; adjusted net profit  was RMB 92.0 million, up 9.0%.By service line, healthcare-related services revenue was RMB 926.3 million, up 50.2%, led by digital marketing revenue of RMB 712.6 million, up 52.1%.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Qingsong Health Corporation published the original content used to generate th","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260323:nNDLbX18J7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02661","BK1219"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":5,"totalSize":107,"code":"91000000","status":"200"}]}}